SCHEMBL5391100

SCHEMBL5391100

Cc1ccc(C(=O)Nc2ccc(Nc3nc(N4C[C@H](N)C[C@H](N)C4)nc(N4C[C@H](O)C[C@@H](O)C4)n3)cc2O)cc1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CAMK1D Q8IU85 2/20 0.39
MAPT P10636 4/20 0.38
PTGS2 P35354 2/20 0.36
SMN1; SMN2 Q16637 2/20 0.36
LMNA P02545 1/20 0.36
CYP1A2 P05177 1/20 0.36
CYP3A4 P08684 1/20 0.36
CYP2C9 P11712 1/20 0.36
CYP2C19 P33261 1/20 0.36
GAA P10253 3/20 0.35
ALDH1A1 P00352 3/20 0.35
KDM4E B2RXH2 2/20 0.35
MEN1 O00255 2/20 0.35
KMT2A Q03164 2/20 0.35
POLB P06746 2/20 0.35
CYBB P04839 1/20 0.35
NOX5 Q96PH1 1/20 0.35
NOX3 Q9HBY0 1/20 0.35
NOX4 Q9NPH5 1/20 0.35
NOX1 Q9Y5S8 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14428604 1.00 CAMK1D (0.39) CAMK1DMAPTPTGS2SMN1; SMN2LMNA
SCHEMBL5400876 0.98 CAMK1D (0.39) CAMK1DMAPTPTGS2SMN1; SMN2LMNA
SCHEMBL5380923 0.96 MAPT (0.41) MAPTPTGS2SMN1; SMN2LMNACYP1A2
SCHEMBL5391464 0.95 MAPT (0.40) MAPTPTGS2SMN1; SMN2LMNACYP1A2
SCHEMBL14503569 0.95 MAPT (0.40) MAPTPTGS2SMN1; SMN2LMNACYP1A2
SCHEMBL5384918 0.94 MAPT (0.38) MAPTPTGS2SMN1; SMN2LMNACYP1A2
SCHEMBL14428629 0.93 MAPT (0.39) MAPTPTGS2SMN1; SMN2LMNACYP1A2
SCHEMBL5396993 0.92 SCN9A (0.40) CAMK1DMAPTSMN1; SMN2LMNAGAA
SCHEMBL14428608 0.92 SCN9A (0.40) CAMK1DMAPTSMN1; SMN2LMNAGAA
SCHEMBL5375999 0.92 IDH2 (0.43) MAPTPTGS2SMN1; SMN2LMNACYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070197533-A1 Antibacterial 3,5-diaminopiperidine-substituted aromatic and heteroaromatic compounds ANADYS PHARMACEUTICALS, INC. (US) 2007-08-23 US disclosed
US-7223759-B2 Antibacterial 3,5-diaminopiperidine-substituted aromatic and heteroaromatic compounds ANADYS PHARMACEUTICALS, INC. (US) 2007-05-29 US disclosed
US-20050239827-A1 Antibacterial 3,5-diaminopiperidine-substituted aromatic and heteroaromatic compouds ANADYS PHARMACEUTICALS, INC. 2005-10-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070197533-A1 Antibacterial 3,5-diaminopiperidine-substituted aromatic and heteroaromatic compounds DDC, DPP3, AMPD3 CAMK1D 4720/4885MAPT 2536/4885PTGS2 4416/4885
US-20050239827-A1 Antibacterial 3,5-diaminopiperidine-substituted aromatic and heteroaromatic compouds AMPD3, AAAS, PEPD CAMK1D 4367/4885MAPT 2630/4885PTGS2 4131/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.